Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02703259 · ClinicalTrials.gov registry record · Phase 4
Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management
A Phase 4 study, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- Phase 4
- Development phase
- 137
- Enrollment target
NCT02703259 is a Phase 4 study that has completed, run by Christiana Care Health Services. The registered enrollment target is 137 participants.
The verdict
NCT02703259, a Phase 4 study, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 137 participants
- Enrollment target
Study Summary
The purpose of the investigators' study is to assess the efficacy of a single dose of preoperative gabapentin within an enhanced recovery after surgery protocol in acute postoperative pain reduction for women undergoing a minimally invasive hysterectomy. Participants who consent to participate will be randomized to either a control group without gabapentin or to a study arm and receive gabapentin 600 mg prior to their planned surgery. The investigators will collect data on postoperative narcotic use, subjective pain as rated by a numeric pain scale, in addition to any adverse effects of single dose gabapentin use.
Interventions
- DRUG Acetaminophen
- DRUG Celecoxib
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02703259
The ClinicalTrials.gov registry entry for NCT02703259 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christiana Care Health Services, which has 82 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Acetaminophen is the first listed.
NCT02703259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02703259 about?
NCT02703259 is a clinical study titled "Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management". The purpose of the investigators' study is to assess the efficacy of a single dose of preoperative gabapentin within an enhanced recovery after surgery protocol in acute postoperative pain reduction for women undergoing a minimally invasive hysterectomy. Participants who consent to participate will ...
What is the current status of trial NCT02703259?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 137 participants. The study started on 2016-06. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02703259?
The interventions under investigation include: Acetaminophen (DRUG), Celecoxib (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT02703259?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.